Abstract
AbstractThe new catalysts are applied to the asymmetric reduction of a wide range of ketimines, the syntheses of enantiopure α‐amino esters, γ‐ and δ‐lactams, isoindolinones, and pharmaceutically relevant targets, such as (R)‐(+)‐salsolidine and (R)‐(+)‐crispine A.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have